NCT00350532View on ClinicalTrials.gov

Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Pain
Interventions
DRUG

clonidine

Patients will receive intrathecal clonidine (or clonidine injected into cerebrospinal fluid)

DRUG

clonidine

Patients will receive intrathecal clonidine (or clonidine injected into cerebrospinal fluid)

Trial Locations (2)

27103

The Center for Clinical Research, 145 Kimel Park Drive, Winston-Salem

27157-1009

Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00350532 - Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain | Biotech Hunter | Biotech Hunter